Karyopharm Therapeutics' IPO

Karyopharm Therapeutics raised a round of funding on November 06, 2013. Investors include Public.

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing small molecule modulators of nuclear transport. Karyopharm's selective inhibitors of nuclear export (SINE) function by tra…

Articles about Karyopharm Therapeutics' IPO: